AIDS began when a virus living harmlessly in chimpanzees crossed into humans in central Africa, most likely in the early 1900s. The virus, now called HIV-1, adapted to its new human host and spread slowly for decades before exploding into a global pandemic. The story involves hunting, colonial-era medicine, rapid urbanization, and international travel, each playing a role in transforming a local infection into a worldwide crisis.
The Virus Jumped From Chimpanzees
HIV-1, the strain responsible for the vast majority of AIDS cases worldwide, originated in a subspecies of chimpanzee called Pan troglodytes troglodytes, found in southern Cameroon, Gabon, and the Republic of Congo. These chimps carried their own version of the virus, called SIV (simian immunodeficiency virus), which didn’t make them sick. Humans most likely picked it up through hunting and butchering chimps for bushmeat, exposing themselves to infected blood through cuts or wounds.
Genetic analysis of the virus suggests this wasn’t a single unlucky event. HIV-1 actually entered humans on at least four separate occasions, producing distinct viral groups labeled M, N, O, and P. Group M is the one that matters most: it’s responsible for more than 90% of all HIV infections worldwide and is the strain behind the global pandemic. The other groups remained rare and geographically contained.
When the First Crossover Happened
Scientists have used a technique called molecular clock analysis to estimate when HIV first appeared in humans. By measuring how much the virus has mutated over time and working backward, researchers at several institutions have calculated that the ancestor of HIV-1 group M diverged from its closest chimpanzee virus no later than about 1853, with a likely range between 1799 and 1904. That doesn’t necessarily mean someone was infected that year. It means the human and chimpanzee viral lineages split by then, setting an upper bound on when the jump could have occurred.
The oldest confirmed HIV-positive human sample comes from a blood specimen collected in Kinshasa, in what is now the Democratic Republic of the Congo, in 1960. A second sample dates to 1959 from the same city. By that point, the virus had already diversified enough genetically that scientists could tell it had been circulating in humans for several decades. Most estimates place the start of sustained human-to-human transmission somewhere around the 1920s.
Kinshasa: Where the Epidemic Took Hold
The virus may have entered humans in rural Cameroon, but it was Kinshasa (then called Léopoldville) where it gained a foothold. A 2014 study from the University of Oxford reconstructed the early spread using genetic data and colonial-era records, identifying a “perfect storm” of factors between the 1920s and 1950s that allowed the virus to amplify and spread.
Kinshasa was one of the best-connected cities in central Africa during Belgian colonial rule. Its railway network funneled enormous numbers of people through the city. By the late 1940s, over one million passengers were traveling through Kinshasa by rail each year, connecting it to mining towns and other urban centers across the Congo. This constant movement gave the virus access to new populations faster than it could burn out in any single community.
Two other factors likely accelerated transmission. The city’s growing sex trade created conditions for rapid sexual spread. And public health campaigns against diseases like yaws and syphilis relied heavily on injectable treatments administered with reusable needles and syringes. Resources were scarce: records show that during earlier vaccination drives, as few as six syringes were used to vaccinate 90,000 people. In the 1950s, a UNICEF campaign against yaws delivered 12 million injections of penicillin across Central Africa. The routine reuse of unsterilized needles would have been extraordinarily efficient at passing a bloodborne virus from person to person, potentially helping a slow-moving infection gain enough momentum to sustain itself.
HIV-2: A Second, Separate Crossover
There’s actually a second type of HIV. HIV-2 came from an entirely different primate, the sooty mangabey, a monkey found in West Africa. It crossed into humans through at least two independent transmission events, both linked to mangabeys living in the Taï forest in Ivory Coast. Additional, rarer groups of HIV-2 trace back to mangabey populations in Liberia and Sierra Leone.
HIV-2 is far less transmissible than HIV-1 and progresses to AIDS much more slowly. It has remained largely confined to West Africa and has never driven a global epidemic. When people refer to “the AIDS pandemic,” they’re talking about HIV-1 group M.
How the Virus Reached the Americas
For decades, the popular assumption was that AIDS started in the United States, where it was first recognized in 1981. Genetic evidence tells a different story. HIV-1 subtype B, the strain that dominates in the Americas and Europe, traveled from Africa to Haiti before reaching North America.
A landmark study published in the Proceedings of the National Academy of Sciences found that all Haitian and Haiti-linked viral strains occupied the earliest-branching positions within subtype B’s family tree. There would be virtually no chance of this pattern if Haiti’s epidemic had come from the United States. Instead, the data points to the virus arriving in Haiti sometime between 1962 and 1970, likely carried by Haitian professionals who had been working in the newly independent Congo during the 1960s.
From Haiti, the virus entered the United States in the late 1960s or early 1970s, possibly through returning American travelers or through exported blood products. It circulated undetected for roughly a decade before doctors in Los Angeles and New York began noticing unusual clusters of rare infections in 1981, the cases that would eventually be recognized as AIDS.
Why It Took So Long to Notice
One of the most striking aspects of HIV’s history is how long it circulated before anyone knew it existed. The virus was present in humans for roughly 60 years before the first AIDS cases were identified. Several features of the disease explain this. HIV has an unusually long incubation period: a person can carry the virus for years, sometimes a decade or more, before developing symptoms. During that time, they can unknowingly transmit it to others. In regions with limited healthcare infrastructure, the opportunistic infections that eventually killed people with AIDS (tuberculosis, pneumonia, certain cancers) were common enough on their own that no one connected them to a single underlying cause.
By the time the world recognized AIDS as a new disease in the early 1980s, the virus had already spread to five continents. The long, invisible fuse between the initial crossover and the recognized epidemic is what made HIV so devastating. By the time public health systems could respond, the pandemic was already global.